迈瑞拟在港二次IPO，预计募资78亿港元以上

Group 1 - The core viewpoint of the article is that Mindray Medical, a mainland medical device manufacturer listed in A-shares, is considering a secondary IPO in Hong Kong, aiming to raise at least $1 billion (approximately 7.8 billion HKD) [1] - Mindray Medical has engaged potential advisors to discuss the possible share issuance, positioning itself to become one of the largest mainland companies seeking a second listing in Hong Kong [1] - If successful, this Hong Kong listing will further solidify Mindray's position in the international market and accelerate its globalization process, providing additional funds for R&D innovation and technology upgrades to better serve global healthcare demands [1]